The CSE warmly welcomed Planet Based Foods Global Inc. (CSE:PBF) for a virtual Market Open on January 19, 2022.
Planet Based Foods is focused on producing natural, low processed, and nutritional choices that are better for people and the planet. They currently offer a high quality, cost-efficient vegan meat alternative derived from hemp proteins that includes burgers, breakfast sausages, burger crumbles, and sausage crumbles.
CEO Braelyn Davis and other members of the amazing Planet Based Foods team kicked off the day’s trading at the virtual Market Open.
“Planet Based Foods represents another welcome addition to CSE’s stable of plant-based food companies who are leading the charge toward a healthier and more sustainable future,” noted CSE CEO Richard Carleton.
Davis added, “We are thrilled to be listed on the CSE and share our sustainable hemp superfoods with the world!”
For more details about the CSE, including information on other Market Opens, please visit theCSE websiteor follow us onsocial media.
CSE’s Barrington Miller is joined by Adriana Kertzer, Co-Founder of Plant Medicine Law Group, to discuss the unique aspects of representing clients in the cannabis and psychedelics sectors, ongoing policy and regulation issues, and what makes their law firm different from others in this space. The conversation also highlights Adriana’s thoughts on how she sees the plant medicine landscape evolving.
Here’s an overview of what Barrington and Adriana discuss in this edition of the “Exchange for Entrepreneurs” podcast:
0:00 – Introducing Adriana Kertzer and Plant Medicine Law Group
4:13 – Client segments across the psychedelic and cannabis industries
7:43 – A diversity of opinions on plant medicine policy
15:40 – Legality and the psychedelic ecosystem
23:49 – Unique differentiators of Plant Medicine Law Group
28:28 – Going public and being part of a larger community
About Plant Medicine Law Group Plant Medicine Law Group expands equitable and legal access to plant medicine by helping companies in the psychedelic and cannabis industries thrive in a complex, emerging market. Their strategic expertise empowers clients to successfully launch, fund and scale their business.
CSE’s Barrington Miller is joined by Iris Bincovich, CEO of InnoCan Pharma (CSE:INNO) to discuss the company’s focus as a specialty pharmaceutical company including the development of products that harness the unique properties of Cannabinoids combined with smart delivery formulations. The conversation also highlights the importance – and impact – that achieving milestones has had on the company’s life as a public company.
Here’s an overview of what Barrington and Iris discuss in this edition of the “Exchange for Entrepreneurs” podcast:
0:00 – Re-introducing Iris Bincovich and Innocan Pharma
3:31 – Iris’ background in chemistry and the healthcare industry
5:22 – Exporting Israeli innovation across the globe
8:41 – Going public in Canada and the importance of meeting milestones
13:47 – Opportunities for growth in 2022
16:19 – Accessing Innocan’s products
18:35 – Iris’ favourite restaurant
About InnoCan Pharma Corporation The Corporation’s business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products; (ii) research and development of non-pharmaceutical products for third parties in exchange for fees and/or royalties; and (iii) research and development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales.
CSE’s James Black is joined by Mehran Ehsan, CEO of Permex Petroleum (CSE:OIL) to discuss the company’s operations in the Permian Basin in Texas and New Mexico and why Mehran envisions a future where oil and natural gas contribute to world powered by “clean” energy.
Here’s an overview of what James and Mehran discuss in this edition of the “Exchange for Entrepreneurs” podcast:
0:00 – Introducing Mehran Ehsan and Permex Petroleum
0:45 – Why the Oil and Natural Gas Industry?
1:58 – What is impacting gas prices?
3:50 – The impact of Omicron on price
5:50 – What is Permex’s business model?
7:30 – The role of a junior in the Permian Basin
10:20 – Generating royalty interests
11:45 – JP Bryan’s impact on Permex
13:35 – Addressing “dirty oil”
About Permex Petroleum Corporation
Permex Petroleum is a uniquely positioned junior Oil & Gas company with assets and operations across the Permian Basin of west Texas and the Delaware Sub-Basin of south east New Mexico. Permex has a current focus on identifying, evaluating and acquiring oil and natural gas assets in North America and enhancing and developing its currently held oil and natural gas assets in Texas and New Mexico. Permex owns and operates on Private, State and Federal land.
The CSE warmly welcomed The Fresh Factory B.C. Ltd. (CSE:FRSH) for a virtual Market Open on December 3, 2021.
The Fresh Factory is a vertically integrated company focused on accelerating the growth of the plant-based, clean-label food and beverage brands of tomorrow. They own or partner with these brands to develop, manufacture, and sell products made from fresh produce and recognizable ingredients. As a B Corporation, The Fresh Factory is ESG-focused, and driven to make a lighter, greener impact on the environment and a stronger, positive impact on local communities and the food supply system as a whole.
CEO Bill Besenhofer and other members of the amazing team from The Fresh Factory kicked off the day’s trading at the virtual Market Open.
For more details about the CSE, including information on other Market Opens, please visit theCSE websiteor follow us onsocial media.
The CSE warmly welcomed Railtown AI Technologies Inc. (CSE:RAIL) for a virtual Market Open on December 2, 2021.
Railtown AI Technologies develops a software-as-a-service artificial intelligence solution that helps software development teams detect, analyze and fix errors quickly in their development projects. Real-time exception monitoring and alerting permits developers, team managers and executives to quickly locate, understand and correct errors in their software development projects, and their root causes, preventing system and application downtimes.
CTO Marwan Haddad, CEO Cory Brandolini, and other members of the amazing Railtown AI Technologies team kicked off the day’s trading at the virtual Market Open.
For more details about the CSE, including information on other Market Opens, please visit theCSE websiteor follow us onsocial media.
The CSE warmly welcomed Legible Inc. (CSE:READ) for a virtual Market Open on December 1, 2021.
Legible has launched a new digital reading and publishing system, which helps solve key challenges faced by readers, publishers, and authors. Legible is a browser-based, mobile-first, globally distributed publishing and reading platform that allows authors, publishers, and ebook developers the opportunity to create and sell their books in the highest quality multimedia with modern code bases and the full spectrum of HTML.
Founder & CEO Kaleeg Hainsworth and other members of the amazing Legible team kicked off the day’s trading at the virtual Market Open.
For more details about the CSE, including information on other Market Opens, please visit theCSE websiteor follow us onsocial media.
The CSE warmly welcomed Swarmio Media Holdings Inc. (CSE:SWRM) for a virtual Market Open on November 25, 2021.
Swarmio Media is a gaming and esports technology company that provides solutions purpose-built to support the growth of esports communities, esports teams, game developers, and telecom operators. Their solutions, through their wholly-owned subsidiary, include a proprietary patented “smart edge computing” technology and a gamer engagement and monetization platform.
CEO Vijai Karthigesu and other members of the amazing Swarmio Media team kicked off the day’s trading at the virtual Market Open.
For more details about the CSE, including information on other Market Opens, please visit theCSE websiteor follow us onsocial media.
Welcome to the latest issue of the Canadian Securities Exchange Magazine, your source for in-depth stories of entrepreneurs from a wealth of different industries.
Psychedelics has emerged as a rapidly-evolving industry in the last few years. In this issue of Canadian Securities Exchange Magazine, we’re thrilled to share stories of visionary entrepreneurs in this sector.
We shine a spotlight on five publicly-listed psychedelics companies on the CSE who are looking back to older medicines in order to move forward, and developing innovative treatments designed to achieve better health outcomes for people experiencing mental health conditions, chronic pain, addiction, and more.
The CSE-listed companies featured in this issue include:
CSE’s Barrington Miller is joined by Anthony Durkacz, Interim CEO of FSD Pharma (CSE:HUGE) to discuss the company’s recent history and transition from the cannabis-era to new opportunities in the growing psychedelics space.
Here’s an overview of what Barrington and Anthony discuss in this edition of the “Exchange for Entrepreneurs” podcast:
0:00 – Introducing Anthony Durkacz, Interim CEO of FSD Pharma
5:45 – Working back towards a 1Bn market cap
8:10 – The latest investment inLucid Psycheceuticals Inc. and treating MS
10:50 – The psychedelics movement
14:13 – Listing on NASDAQ
About FSD Pharma Inc. FSD Pharma, Inc., is a publicly traded holding company since May 2018.
FSD BioSciences, Inc., a wholly-owned subsidiary, is a specialty biotech pharmaceutical R&D company focused on developing over time multiple applications of its lead compound, FSD201, ultra-micronized palmitoylethanolamide (PEA). Ultra-micro PEA is known to target the CB2 receptors of the endocannabinoid system of the human body and acts by down-regulating the pro-inflammatory cytokines to effectuate an anti-inflammatory response.
The company has successfully completed Phase 1 first-in-human safety and tolerability study for FSD201 and has found the compound to be safe with no serious adverse side effects. This study also validated considerable scientific literature already published in the European Union that claims safety and tolerability of micro-PEA. Ultra-micro PEA is currently beings dispensed in Italy and Spain as a prescription based medical food supplement since 2004.
The company received permission from the Food and Drug Administration (FDA) on June 1, 2020 to submit an Investigational New Drug Application (IND) for the use of FSD201 to treat COVID-19, the disease caused by the SARS-CoV-2 virus.
Severe COVID-19 is characterized by an over-exuberant inflammatory response that may lead to a cytokine storm and ultimately death. The Company is focused on developing FSD201 for its anti-inflammatory properties to avoid the cytokine storm associated with acute lung injury in hospitalized COVID-19 patients.
